Share
Etienne Montagut
PharmaLogic Holdings Corp. ("PharmaLogic"), a leading contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals, has appointed Etienne Montagut as President and Chief Executive Officer.
Mr. Montagut, who has been serving as President for the past year, succeeds Steve Chilinski, who retired as CEO on June 1, 2025, after 13 years of leading the company through significant growth.
Mr. Chilinski will continue to support PharmaLogic as Executive Chairman of the Board.
With more than 25 years of senior leadership experience in the pharmaceutical sector, Mr. Montagut has a proven track record of driving growth and leading strategic transformations across global markets. Before joining PharmaLogic, he held executive positions at Lantheus, GE HealthCare, and Ipsen, where he contributed to expanding market presence and operational excellence.
In his new role, Mr. Montagut will focus on advancing PharmaLogic’s mission to deliver high-quality radiopharmaceutical solutions and foster continued growth in the rapidly evolving CDMO landscape.
